Joelle Julius Nicolaas Daems
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Joelle Julius Nicolaas Daems has a total of 97 co-authors. Here are the top co-authors by number of shared publications:
- Harald Thune Jorstad
Cardiology, Amsterdam University Medical Centres, Amsterdam, The Netherlands
10 shared publications - Juliette C. Van Hattum
Department of Cardiology, Amsterdam UMC Location University of Amsterdam , Room D3-221, Meibergdreef 9, 1105 AZ Amsterdam
7 shared publications - S. Matthijs Boekholdt
Department of Cardiology (B.J.B., S.M.B.), Amsterdam UMC, location University of Amsterdam, the Netherlands
7 shared publications - Adrienne van Randen
Amsterdam Cardiovascular Sciences, Heart Failure and Arrhythmias, University of Amsterdam , Amsterdam
6 shared publications - Maarten A. Van Diepen
Department of Cardiology, Amsterdam University Medical Centre, Amsterdam Cardiovascular Sciences, Amsterdam Movement Sciences , Meibergdreef 9, 1105 AZ Amsterdam
6 shared publications - Sjoerd M. Verwijs
Department of Cardiology, Amsterdam University Medical Centers, Amsterdam, the Netherlands; Amsterdam Cardiovascular Sciences, University of Amsterdam, Amsterdam, the Netherlands
6 shared publications
Latest Publications
- Open Access
- 30 August 2026
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
Sport Type Alone Does Not Reliably Predict Distinct Cardiac Phenotypes in Athletes
Aims: : Sport-type classification frameworks recommended by European (ESC) and American (AHA/ACC) guidelines are used to contextualize cardiac remodelling in athletes but remain unvalidated against cardiac magnetic resonance (CMR) phenotypes. We aimed to evaluate whether sport classifications predict CMR-determined cardiac remodelling phenotypes in elite athletes. Methods and Results: : We included 1,024 individuals: 775 elite athletes (310 women, 48 disciplines) and 249 controls. Athletes were classified by the ESC (four-category) and AHA/ACC (static–dynamic, four-quadrant) frameworks. CMR metrics were transformed to sex-specific z-scores (remodelling: z≥1.645). Because no CMR convention defines geometric phenotypes in athletes, the most strongly associated CMR metric was used to define each framework's assumed phenotype. Performance was evaluated at population (R2) and individual (balanced accuracy) levels. ESC categories were most strongly associated with RVEDV (R2=0.170); RV remodelling prevalence increased from skill to endurance (8.3%–62.2%; OR 3.82 per category; P<0.001). The AHA/ACC static component was most strongly associated with LV mass (R2=0.077) and the dynamic component with RVEDV (R2=0.072). Individual-level discrimination was poor: balanced accuracy was 34.2% (ESC) and 37.7% (AHA/ACC) (vs 25% chance). LV mass and RVEDV showed coupled increases (R2=0.23), with 67% of athletes demonstrating concordant patterns rather than discrete static or dynamic phenotypes. Misclassification was most pronounced for predominantly high-static athletes, of whom 73.8% showed normal geometry rather than expected LV hypertrophy (17.5%). Conclusions: : ESC and AHA/ACC sport classifications capture population-level remodelling but cannot reliably be used to predict individual cardiac phenotypes. In individual athletes interpretation should prioritise observed mass-volume relationships and the overall clinical context rather than sport type alone.
- 30 August 2026
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
Open AccessSport Type Alone Does Not Reliably Predict Distinct Cardiac Phenotypes in Athletes
Aims: : Sport-type classification frameworks recommended by European (ESC) and American (AHA/ACC) guidelines are used to contextualize cardiac remodelling in athletes but remain unvalidated against cardiac magnetic resonance (CMR) phenotypes. We aimed to evaluate whether sport classifications predict CMR-determined cardiac remodelling phenotypes in elite athletes. Methods and Results: : We included 1,024 individuals: 775 elite athletes (310 women, 48 disciplines) and 249 controls. Athletes were classified by the ESC (four-category) and AHA/ACC (static–dynamic, four-quadrant) frameworks. CMR metrics were transformed to sex-specific z-scores (remodelling: z≥1.645). Because no CMR convention defines geometric phenotypes in athletes, the most strongly associated CMR metric was used to define each framework's assumed phenotype. Performance was evaluated at population (R2) and individual (balanced accuracy) levels. ESC categories were most strongly associated with RVEDV (R2=0.170); RV remodelling prevalence increased from skill to endurance (8.3%–62.2%; OR 3.82 per category; P<0.001). The AHA/ACC static component was most strongly associated with LV mass (R2=0.077) and the dynamic component with RVEDV (R2=0.072). Individual-level discrimination was poor: balanced accuracy was 34.2% (ESC) and 37.7% (AHA/ACC) (vs 25% chance). LV mass and RVEDV showed coupled increases (R2=0.23), with 67% of athletes demonstrating concordant patterns rather than discrete static or dynamic phenotypes. Misclassification was most pronounced for predominantly high-static athletes, of whom 73.8% showed normal geometry rather than expected LV hypertrophy (17.5%). Conclusions: : ESC and AHA/ACC sport classifications capture population-level remodelling but cannot reliably be used to predict individual cardiac phenotypes. In individual athletes interpretation should prioritise observed mass-volume relationships and the overall clinical context rather than sport type alone.
- Open Access
- 13 February 2026
- Published by Elsevier in JACC: Case Reports
- Vol. 31 (12) , 106939
Aortic Root Dilation in a Masters Dressage Athlete With Familial TAAD
- 13 February 2026
- Published by Elsevier in JACC: Case Reports
- Vol. 31 (12) , 106939
Open AccessAortic Root Dilation in a Masters Dressage Athlete With Familial TAAD
- Open Access
- 1 December 2025
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Imaging
- Vol. 18 (12)
Cardiac Ventricular Hinge Point LGE Is Highly Prevalent and Sex-Dependent in ELITE Athletes
BACKGROUND: Myocardial late gadolinium enhancement (LGE) using cardiac magnetic resonance imaging has been described in older endurance athletes, particularly at the ventricular hinge point. However, data on young, elite athletes are lacking. We therefore quantified the prevalence of hinge point LGE (HP-LGE) in young elite-level athletes. METHODS: We investigated 309 (40% women; median age 25.1 [21.9–29.5] years) asymptomatic athletes included in the ELITE prospective cohort (Evaluation of Lifetime Participation in Intensive Top-level Sports and Exercise cohort), investigating cardiovascular screenings of elite (national-, international-, Olympic-, or Paralympic-) level athletes, including cardiac magnetic resonance imaging with short-axis cine imaging, LGE, and T1-mapping. RESULTS: A total of 124 (40%) athletes had HP-LGE, with a higher prevalence in men compared with women (47% versus 30%; P =0.004). When indexed for body surface area, athletes with HP-LGE had greater left ventricle end-systolic volumes (53±11 mL/m² versus 51±11 mL/m²; P =0.037), right ventricle end-systolic volumes (56±12 mL/m² versus 53±11 mL/m²; P =0.020), lower left ventricle ejection fraction (55.5±5.0% versus 56.7±4.6%; P =0.035), lower right ventricle ejection fraction (53.9±5.0% versus 55.2±4.4%; P =0.021), and smaller estimated global left ventricle extracellular volumes (24.45±2.52% versus 25.27±2.59%; P =0.015). In multivariable regression analyses, male sex was strongly associated with HP-LGE (odds ratio, 3.07 [95% CI, 1.32–7.32]; P =0.010). CONCLUSIONS: HP-LGE is a common finding in asymptomatic, elite athletes and is strongly associated with sex. Lower left ventricle ejection fraction is moderately associated with HP-LGE. Our study’s HP-LGE prevalence indicates that HP-LGE should be interpreted as a feature of the athlete’s heart.
- 1 December 2025
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Imaging
- Vol. 18 (12)
Open AccessCardiac Ventricular Hinge Point LGE Is Highly Prevalent and Sex-Dependent in ELITE Athletes
BACKGROUND: Myocardial late gadolinium enhancement (LGE) using cardiac magnetic resonance imaging has been described in older endurance athletes, particularly at the ventricular hinge point. However, data on young, elite athletes are lacking. We therefore quantified the prevalence of hinge point LGE (HP-LGE) in young elite-level athletes. METHODS: We investigated 309 (40% women; median age 25.1 [21.9–29.5] years) asymptomatic athletes included in the ELITE prospective cohort (Evaluation of Lifetime Participation in Intensive Top-level Sports and Exercise cohort), investigating cardiovascular screenings of elite (national-, international-, Olympic-, or Paralympic-) level athletes, including cardiac magnetic resonance imaging with short-axis cine imaging, LGE, and T1-mapping. RESULTS: A total of 124 (40%) athletes had HP-LGE, with a higher prevalence in men compared with women (47% versus 30%; P =0.004). When indexed for body surface area, athletes with HP-LGE had greater left ventricle end-systolic volumes (53±11 mL/m² versus 51±11 mL/m²; P =0.037), right ventricle end-systolic volumes (56±12 mL/m² versus 53±11 mL/m²; P =0.020), lower left ventricle ejection fraction (55.5±5.0% versus 56.7±4.6%; P =0.035), lower right ventricle ejection fraction (53.9±5.0% versus 55.2±4.4%; P =0.021), and smaller estimated global left ventricle extracellular volumes (24.45±2.52% versus 25.27±2.59%; P =0.015). In multivariable regression analyses, male sex was strongly associated with HP-LGE (odds ratio, 3.07 [95% CI, 1.32–7.32]; P =0.010). CONCLUSIONS: HP-LGE is a common finding in asymptomatic, elite athletes and is strongly associated with sex. Lower left ventricle ejection fraction is moderately associated with HP-LGE. Our study’s HP-LGE prevalence indicates that HP-LGE should be interpreted as a feature of the athlete’s heart.
- Open Access
Comparison of 2D Speckle Tracking Echocardiography and Cardiac MRI Feature Tracking for Bi-Atrial Strain Assessment in Elite Athletes
Background: Data on Feature-tracking Cardiac Magnetic Resonance imaging (FT-CMR) in athletes is limited, and direct comparison of Speckle Tracking Transthoracic Echocardiography (STE) and FT-CMR-derived bi-atrial strain are lacking. Aim: To compare STE and FT-CMR longitudinal bi-atrial strain in a well-defined cohort of elite athletes and to determine the level of agreement between these modalities. Methods: Agreement between FT-CMR and STE derived bi-atrial strain was assessed in elite athletes from the Evaluation of Lifetime participation in Intensive Top-level sports and Exercise (ELITE) cohort (>16 years; exercise >10h/week; (inter)national or Olympic level). Absolute agreement was evaluated using a two-way mixed-effects model (ICC(3,1)). Results: We included 194 elite athletes (51% women; mean age 30 ±7 years). The interval between TTE and CMR was p < .001), conduit-(0.39 (95% CI: 0.26 – 0.50, p < .001), and contractile strain (0.48 (95% CI: 0.36 – 0.58, p < .001). There was no agreement in right atrial reservoir-(0.02, 95% CI: -0.12 – 0.16, p = .4) and conduit strain (0.09, 95% CI: -0.07 – 0.21, p = .17. There was poor agreement in RA contractile strain (0.218, 95% CI 0.080 – 0.48, p = 0.001). Conclusion: There are important modality-dependent differences in bi-atrial strain in elite athletes. The poor-to-moderate agreement between longitudinal STE and FT-CMR left atrial strain and a lack of agreement in right atrial strain highlights the need to interpret observed values in the context of modality-specific elite athlete reference ranges. Clinicians should avoid direct cross-modality comparison in elite athlete populations.
Open AccessComparison of 2D Speckle Tracking Echocardiography and Cardiac MRI Feature Tracking for Bi-Atrial Strain Assessment in Elite Athletes
Background: Data on Feature-tracking Cardiac Magnetic Resonance imaging (FT-CMR) in athletes is limited, and direct comparison of Speckle Tracking Transthoracic Echocardiography (STE) and FT-CMR-derived bi-atrial strain are lacking. Aim: To compare STE and FT-CMR longitudinal bi-atrial strain in a well-defined cohort of elite athletes and to determine the level of agreement between these modalities. Methods: Agreement between FT-CMR and STE derived bi-atrial strain was assessed in elite athletes from the Evaluation of Lifetime participation in Intensive Top-level sports and Exercise (ELITE) cohort (>16 years; exercise >10h/week; (inter)national or Olympic level). Absolute agreement was evaluated using a two-way mixed-effects model (ICC(3,1)). Results: We included 194 elite athletes (51% women; mean age 30 ±7 years). The interval between TTE and CMR was p < .001), conduit-(0.39 (95% CI: 0.26 – 0.50, p < .001), and contractile strain (0.48 (95% CI: 0.36 – 0.58, p < .001). There was no agreement in right atrial reservoir-(0.02, 95% CI: -0.12 – 0.16, p = .4) and conduit strain (0.09, 95% CI: -0.07 – 0.21, p = .17. There was poor agreement in RA contractile strain (0.218, 95% CI 0.080 – 0.48, p = 0.001). Conclusion: There are important modality-dependent differences in bi-atrial strain in elite athletes. The poor-to-moderate agreement between longitudinal STE and FT-CMR left atrial strain and a lack of agreement in right atrial strain highlights the need to interpret observed values in the context of modality-specific elite athlete reference ranges. Clinicians should avoid direct cross-modality comparison in elite athlete populations.
- Open Access
- 25 June 2025
- Published by Elsevier in JACC: Case Reports
- Vol. 30 (16) , 104250
Multimodality Imaging in Anomalous Aortic Origin of the Coronary Arteries
- 25 June 2025
- Published by Elsevier in JACC: Case Reports
- Vol. 30 (16) , 104250
Open AccessMultimodality Imaging in Anomalous Aortic Origin of the Coronary Arteries
- Open Access
- 2 June 2025
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 26 (7) , 1199-1207
Extreme phenotypes of the female athlete’s heart: a sports-specific cardiac magnetic resonance imaging study
Aims: Differentiating physiological exercise-induced cardiac remodelling (EICR) from pathology is challenging, especially in female athletes, where studies using state-of-the-art imaging techniques are lacking. We aimed to investigate extreme phenotypes of EICR in female elite athletes using magnetic resonance imaging (MRI). Methods and results: Cross-sectional, multicentre study in female elite athletes using contrast-enhanced cardiac MRI. Left and right ventricle (LV, RV) indices and LV mass (LVM)-to-LV end-diastolic volume (EDV) ratios were investigated, indexed by body surface area (BSA). Cardiac remodelling was determined comparing cardiac MRI metrics to female reference values, stratified by ESC sports classification (endurance, mixed, power/skill). In 173 female elite athletes (median age 25 years, median 18 h training/week, 97% Caucasian), mean LV EDV/BSA and LVM/BSA were 108 ± 13 mL/m2 and 50 ± 10 g/m2, with lower LVM/LV EDV ratios (0.5 ± 0.1) than the general population (0.7 ± 0.1 g/mL; P < 0.001). Most athletes (71%) had isolated LV EDV increases; LVM increases (18%) commonly coincided with LV EDV increases. Compared with the general population (45 ± 7 g/m2), only mixed (48 ± 9 g/m2; P = 0.021) and endurance athletes (53 ± 11 g/m2; P < 0.001) exhibited greater mean LVM with endurance athletes surpassing mixed athletes (P = 0.004). Mixed and endurance showed comparably greater median biventricular EDV compared with power/skill athletes [LV: 109 (103–119) and 111 (101–118) vs. 99 (92–105); RV: 110 (103–118) and 112 (105–124) vs. 101 (95–104) mL/m2; P < 0.001]. Maximum wall thickness > 11 mm was rare (2%). Global T1 time was 968 ± 22 ms; extracellular volume was 25 ± 4%. Conclusion: Female elite athletes, particularly endurance-trained athletes, display EICR marked by increased ventricular volumes, without prominent increases in LVM or wall thickness. Trial Registration Number: NL9328
- 2 June 2025
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 26 (7) , 1199-1207
Open AccessExtreme phenotypes of the female athlete’s heart: a sports-specific cardiac magnetic resonance imaging study
Aims: Differentiating physiological exercise-induced cardiac remodelling (EICR) from pathology is challenging, especially in female athletes, where studies using state-of-the-art imaging techniques are lacking. We aimed to investigate extreme phenotypes of EICR in female elite athletes using magnetic resonance imaging (MRI). Methods and results: Cross-sectional, multicentre study in female elite athletes using contrast-enhanced cardiac MRI. Left and right ventricle (LV, RV) indices and LV mass (LVM)-to-LV end-diastolic volume (EDV) ratios were investigated, indexed by body surface area (BSA). Cardiac remodelling was determined comparing cardiac MRI metrics to female reference values, stratified by ESC sports classification (endurance, mixed, power/skill). In 173 female elite athletes (median age 25 years, median 18 h training/week, 97% Caucasian), mean LV EDV/BSA and LVM/BSA were 108 ± 13 mL/m2 and 50 ± 10 g/m2, with lower LVM/LV EDV ratios (0.5 ± 0.1) than the general population (0.7 ± 0.1 g/mL; P < 0.001). Most athletes (71%) had isolated LV EDV increases; LVM increases (18%) commonly coincided with LV EDV increases. Compared with the general population (45 ± 7 g/m2), only mixed (48 ± 9 g/m2; P = 0.021) and endurance athletes (53 ± 11 g/m2; P < 0.001) exhibited greater mean LVM with endurance athletes surpassing mixed athletes (P = 0.004). Mixed and endurance showed comparably greater median biventricular EDV compared with power/skill athletes [LV: 109 (103–119) and 111 (101–118) vs. 99 (92–105); RV: 110 (103–118) and 112 (105–124) vs. 101 (95–104) mL/m2; P < 0.001]. Maximum wall thickness > 11 mm was rare (2%). Global T1 time was 968 ± 22 ms; extracellular volume was 25 ± 4%. Conclusion: Female elite athletes, particularly endurance-trained athletes, display EICR marked by increased ventricular volumes, without prominent increases in LVM or wall thickness. Trial Registration Number: NL9328
- Open Access
- 18 April 2025
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 26 (7) , 1208-1216
Native T1 mapping times are strongly influenced by elite athlete status
Aims: Limited data indicates that athletes’ hearts demonstrate decreased native T1, but this assertion has not been replicated in large cohorts of extreme phenotypes of elite athletes. Therefore, we investigated differences in native T1 between elite athletes and healthy non-athletic controls. Methods and Results: Cross-sectional analysis comparing native T1 between elite athletes (≥16 years; ≥10 h of exercise/week) and age-matched healthy non-athletic controls. All participants underwent cardiovascular magnetic resonance imaging on a 1.5 tesla MRI machine. We included 240 elite athletes [50% women; age 28 years (25–32)] and 80 non-athlete healthy controls [50% women; age 28 years (23–39)]. Elite athletes demonstrated lower native T1 than non-athlete healthy controls (960 ± 21 ms vs. 983 ± 26 ms, P < 0.001), also when stratified by sex (male athletes vs. controls 953 ms ±19 vs. 968 ms ±16, P < 0.001; female athletes vs. controls 968 ms ±20 vs. 999 ms ±25, P < 0.001). Multivariate linear regression identified elite athlete status (β = −13.34, P < 0.001), heart rate (β = 0.6, P < 0.001), average left-ventricular wall thickness (β = −8.28, P < 0.001) and native blood pool T1 (β = 0.09, P < 0.001) as independent determinants of native T1 (adjusted R2 = 51.4%, P < 0.001). Conclusion: Elite athletes have lower native T1 compared with non-athletes, both in women and men. Athlete- and sex-specific reference ranges should be applied when interpreting native T1 in athlete populations, especially in female athletes.
- 18 April 2025
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 26 (7) , 1208-1216
Open AccessNative T1 mapping times are strongly influenced by elite athlete status
Aims: Limited data indicates that athletes’ hearts demonstrate decreased native T1, but this assertion has not been replicated in large cohorts of extreme phenotypes of elite athletes. Therefore, we investigated differences in native T1 between elite athletes and healthy non-athletic controls. Methods and Results: Cross-sectional analysis comparing native T1 between elite athletes (≥16 years; ≥10 h of exercise/week) and age-matched healthy non-athletic controls. All participants underwent cardiovascular magnetic resonance imaging on a 1.5 tesla MRI machine. We included 240 elite athletes [50% women; age 28 years (25–32)] and 80 non-athlete healthy controls [50% women; age 28 years (23–39)]. Elite athletes demonstrated lower native T1 than non-athlete healthy controls (960 ± 21 ms vs. 983 ± 26 ms, P < 0.001), also when stratified by sex (male athletes vs. controls 953 ms ±19 vs. 968 ms ±16, P < 0.001; female athletes vs. controls 968 ms ±20 vs. 999 ms ±25, P < 0.001). Multivariate linear regression identified elite athlete status (β = −13.34, P < 0.001), heart rate (β = 0.6, P < 0.001), average left-ventricular wall thickness (β = −8.28, P < 0.001) and native blood pool T1 (β = 0.09, P < 0.001) as independent determinants of native T1 (adjusted R2 = 51.4%, P < 0.001). Conclusion: Elite athletes have lower native T1 compared with non-athletes, both in women and men. Athlete- and sex-specific reference ranges should be applied when interpreting native T1 in athlete populations, especially in female athletes.
- Open Access
Long-term cardiac follow-up of athletes infected with SARS-CoV-2 after resumption of elite-level sports
Objective Longitudinal consequences and potential interactions of COVID-19 and elite-level sports and exercise are unclear. Therefore, we determined the long-term detrimental cardiac effects of the interaction between SARS-CoV-2 infection and the highest level of sports and exercise. Methods This prospective controlled study included elite athletes from the Evaluation of Lifetime participation in Intensive Top-level sports and Exercise cohort. Athletes infected with SARS-CoV-2were offered structured, additional cardiovascular screenings, including cardiovascular MRI (CMR). We compared ventricular volumes and function, late gadolinium enhancement (LGE) and T1 relaxation times, between infected and non-infected elite athletes, and collected follow-up data on cardiac adverse events, ventricular arrhythmia burden and the cessation of sports careers. Results We included 259 elite athletes (mean age 26±5 years; 40% women), of whom 123 were infected (9% cardiovascular symptoms) and 136 were controls. We found no differences in function and volumetric CMR parameters. Four infected athletes (3%) demonstrated LGE (one reversible), compared with none of the controls. During the 26.7 (±5.8) months follow-up, all four athletes resumed elite-level sports, without an increase in ventricular arrhythmias or adverse cardiac remodelling. None of the infected athletes reported new cardiac symptoms or events. The majority (n=118; 96%) still participated in elite-level sports; no sports careers were terminated due to SARS-CoV-2. Conclusions This prospective study demonstrates the safety of resuming elite-level sports after SARS-CoV-2 infection. The medium-term risks associated with SARS-CoV-2 infection and elite-level sports appear low, as the resumption of elite sports did not lead to detrimental cardiac effects or increases in clinical events, even in the four elite athletes with SARS-CoV-2 associated myocardial involvement.
Open AccessLong-term cardiac follow-up of athletes infected with SARS-CoV-2 after resumption of elite-level sports
Objective Longitudinal consequences and potential interactions of COVID-19 and elite-level sports and exercise are unclear. Therefore, we determined the long-term detrimental cardiac effects of the interaction between SARS-CoV-2 infection and the highest level of sports and exercise. Methods This prospective controlled study included elite athletes from the Evaluation of Lifetime participation in Intensive Top-level sports and Exercise cohort. Athletes infected with SARS-CoV-2were offered structured, additional cardiovascular screenings, including cardiovascular MRI (CMR). We compared ventricular volumes and function, late gadolinium enhancement (LGE) and T1 relaxation times, between infected and non-infected elite athletes, and collected follow-up data on cardiac adverse events, ventricular arrhythmia burden and the cessation of sports careers. Results We included 259 elite athletes (mean age 26±5 years; 40% women), of whom 123 were infected (9% cardiovascular symptoms) and 136 were controls. We found no differences in function and volumetric CMR parameters. Four infected athletes (3%) demonstrated LGE (one reversible), compared with none of the controls. During the 26.7 (±5.8) months follow-up, all four athletes resumed elite-level sports, without an increase in ventricular arrhythmias or adverse cardiac remodelling. None of the infected athletes reported new cardiac symptoms or events. The majority (n=118; 96%) still participated in elite-level sports; no sports careers were terminated due to SARS-CoV-2. Conclusions This prospective study demonstrates the safety of resuming elite-level sports after SARS-CoV-2 infection. The medium-term risks associated with SARS-CoV-2 infection and elite-level sports appear low, as the resumption of elite sports did not lead to detrimental cardiac effects or increases in clinical events, even in the four elite athletes with SARS-CoV-2 associated myocardial involvement.
- 10 August 2023
- Published by BMJ in British Journal of Sports Medicine
- Vol. 57 (21) , 1400-1402
Cardiac sequelae in athletes following COVID-19 vaccination: evidence and misinformation
The recognition of myocarditis as a rare side effect of SARS-CoV-2 mRNA vaccination has sparked a global debate on vaccine safety, especially in the realm of sports. The main proposed mechanisms in the pathogenesis of COVID-19 mRNA vaccination-associated myocarditis (C-VAM) are based on the activation of the innate- and adaptive immune system against a susceptible immune-genetic background, including the recognition of mRNA as an antigen by the immune system, molecular mimicry between SARS-CoV-2 spike glycoprotein and cardiac tissue antigens and inflammatory sex-hormone signalling. The relatively younger age of the athlete population hypothetically constellates an increased risk of C-VAM. A subgroup analysis in individuals under 40 years revealed a low incidence of myocarditis following COVID-19 mRNA vaccination when compared to positive SARS-CoV-2 tests. No confirmed cases of athletes experiencing cardiac complications after mRNA vaccination have been reported. Most athletes only reported mild side effects after COVID-19 vaccination. A small but statistically significant decrease in maximal oxygen consumption in recreational athletes occurred after BNT162b2 mRNA booster vaccine administration. The clinical relevance and temporality of which remain to be determined. Many speculative social media reports attribute sudden cardiac arrest/death (SCA/D) in athletes to mRNA vaccination. Large media outlets have thoroughly debunked these claims. There is currently no evidence to support the claim that COVID-19 mRNA vaccination increases the risk of myocardial sequelae or SCA/D in athletes. However, specific vaccine regimen selection and timing may be appropriate to prevent detrimental performance effects.
- 10 August 2023
- Published by BMJ in British Journal of Sports Medicine
- Vol. 57 (21) , 1400-1402
Cardiac sequelae in athletes following COVID-19 vaccination: evidence and misinformation
The recognition of myocarditis as a rare side effect of SARS-CoV-2 mRNA vaccination has sparked a global debate on vaccine safety, especially in the realm of sports. The main proposed mechanisms in the pathogenesis of COVID-19 mRNA vaccination-associated myocarditis (C-VAM) are based on the activation of the innate- and adaptive immune system against a susceptible immune-genetic background, including the recognition of mRNA as an antigen by the immune system, molecular mimicry between SARS-CoV-2 spike glycoprotein and cardiac tissue antigens and inflammatory sex-hormone signalling. The relatively younger age of the athlete population hypothetically constellates an increased risk of C-VAM. A subgroup analysis in individuals under 40 years revealed a low incidence of myocarditis following COVID-19 mRNA vaccination when compared to positive SARS-CoV-2 tests. No confirmed cases of athletes experiencing cardiac complications after mRNA vaccination have been reported. Most athletes only reported mild side effects after COVID-19 vaccination. A small but statistically significant decrease in maximal oxygen consumption in recreational athletes occurred after BNT162b2 mRNA booster vaccine administration. The clinical relevance and temporality of which remain to be determined. Many speculative social media reports attribute sudden cardiac arrest/death (SCA/D) in athletes to mRNA vaccination. Large media outlets have thoroughly debunked these claims. There is currently no evidence to support the claim that COVID-19 mRNA vaccination increases the risk of myocardial sequelae or SCA/D in athletes. However, specific vaccine regimen selection and timing may be appropriate to prevent detrimental performance effects.